Chr. Hansen Holding A/S has entered into an agreement to acquire all of the shares of Jennewein Biotechnologie GmbH, a leading player in the Human Milk Oligosaccharides (HMO) market.
German biotechnology company Jennewein Biotechnologie GmbH has published the latest results from its norovirus research program in the Journal of Biotechnology.
Jennewein Biotechnologie has filed a patent infringement suit against Nestlé concerning the unauthorised use of a human milk oligosaccharide (HMO) purification method for infant formula.